Delcath Begins Phase 2 Study of HEPZATO in Liver-Dominant Metastatic Breast Cancer
As reported on Business Wire, Delcath Systems has announced the enrollment and dosing of the first patient in its global Phase 2 DELUMA clinical trial, marking a significant step in…